Cite
HARVARD Citation
Ader, F. et al. (2022). Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial. Lancet infectious diseases. 22 (2), pp. 209-221. [Online].